Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin adjunctive therapy in children under 4 years with partial onset seizures
NL-OMON40899Phase 3Withdrawn
- Sponsor
- Pfizer
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in epilepsy and Focal onset seizure (3 arms), sponsored by Pfizer. Primary endpoint: Log-transformed double-blind 24-hour seizure rate. Planned start Mar 2014; status: withdrawn.
02
Drugs
pregabalin
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on NL-OMON40899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40899.